CHAPTERS
- 0:00 – 2:04
Metformin/DHEA/Growth Hormone study and the promise of age reversal
Joe and David open by discussing a small but headline-making study suggesting a cocktail of metformin, DHEA, and human growth hormone reduced participants’ biological age by ~2–2.5 years. Sinclair frames it as early evidence that aging might be reversible, not just slowed.
- 2:04 – 4:59
The Horvath epigenetic clock: how “biological age” is measured
Sinclair explains that biological age in the study wasn’t based on telomeres or performance, but on epigenetic marks on DNA (chemical modifications) captured by the Horvath Clock. He suggests these marks may be part of the aging mechanism and potentially modifiable.
- 4:59 – 6:50
Antioxidants disappoint; resveratrol, sirtuins, and how to take it
Joe asks about antioxidants and resveratrol. Sinclair argues most antioxidant approaches have failed to extend lifespan, while resveratrol’s key action is signaling stress-response pathways via sirtuins, not simple antioxidant effects. They discuss dosage and absorption considerations.
- 6:50 – 8:54
NAD biology: CD38, NMN/NR, and combining interventions
They connect the study’s effects to NAD metabolism, highlighting CD38 as an NAD-degrading enzyme that increases with age. Sinclair discusses NMN as an NAD precursor, the need for combination trials, and uncertainties about stacking drugs with lifestyle interventions.
- 8:54 – 12:59
Metformin and exercise: performance tradeoffs and “pulsing” strategy
Joe raises concerns that metformin (and even resveratrol) may blunt training adaptations. Sinclair explains a plausible mitochondrial mechanism and proposes cycling metformin—avoiding it on intense exercise days—to preserve fitness gains while keeping potential longevity benefits.
- 12:59 – 17:59
Heat/cold exposure, hormesis, alcohol, and Sinclair’s travel/workout reality
The conversation shifts into practical lifestyle: Sinclair’s limited training schedule, sauna/cold routines, and Joe’s hot yoga + cryotherapy habits. They touch on hormesis (beneficial stress), overdoing extremes, and alcohol as a common vice that impacts health and aging.
- 17:59 – 34:56
Africa origins journey: predators, tribes, and the “natural vs unnatural” debate
A long detour becomes a philosophical thread: Sinclair’s family trip through Africa and into Israel, witnessing wildlife predation and meeting the Batwa (pygmy) communities. This leads to a critique of “aging is natural so it’s acceptable” and a defense of using science/technology to improve life.
- 34:56 – 48:38
Religion, origin stories, and human behavior from Jerusalem to Kyrgyzstan
From Jerusalem to Mecca imagery, they explore why humans crave shared meaning and ritual. They discuss cultural traditions, sexism in religious spaces, and startling social practices (e.g., kidnapping-based marriages), contrasting scientific and religious ‘origin stories.’
- 48:38 – 1:10:17
Longevity limits, centenarians, and Sinclair’s father as a case study
They return to aging science: maximum lifespan records, genetic variants linked to longevity, and skepticism around extreme age claims. Sinclair describes his 80-year-old father’s remarkable fitness and supplement regimen, using it to illustrate ‘healthspan’ gains and psychological benefits of vitality.
- 1:10:17 – 1:20:08
Fasting, sirtuins, and quantified self: Oura ring, Apple Watch, glucose tracking
Sinclair explains how hunger/fasting activates longevity pathways (sirtuins) and contrasts constant calorie restriction with intermittent/periodic fasting. They discuss self-monitoring tools, blood tests, continuous glucose monitoring, and food-driven glucose spikes (including surprising culprits).
- 1:20:08 – 1:46:29
Food, microbiome, raw milk raids, resistant starch, and “xenohormesis”
The discussion broadens to diet quality: yogurt-making, raw vs processed dairy, fermented foods, and regulatory controversies. Sinclair introduces xenohormesis—the idea that plant stress compounds (polyphenols) signal resilience pathways in animals—connecting colorful foods and wine chemistry to longevity signaling.
- 1:46:29 – 1:50:24
Radiation, air travel, NAD precursors, and supplementation cautions
Sinclair warns that DNA damage from UV and certain radiation can accelerate epigenetic aging, recommending protection like sunscreen and caution with exposure. They discuss NMN/NR availability, his reluctance to endorse brands, and emphasize the limits of human evidence versus animal data.
- 1:50:24 – 1:54:50
CRISPR and gene therapy: from embryo edits to adult treatments
They move to frontier genetics: Sinclair explains CRISPR as programmable DNA editing and discusses controversial embryo editing to disable CCR5 for HIV resistance. The focus shifts to adult gene therapy already entering clinics—especially in eye diseases—setting the stage for rejuvenation approaches.
- 1:54:50 – 2:12:50
Reprogramming aging: Yamanaka factors, retina rejuvenation, and clinical timelines
Sinclair describes his lab’s work using partial cellular reprogramming (Yamanaka factors) delivered by AAV viruses to reset epigenetic age and restore function—demonstrated in mouse vision and optic nerve regeneration. He outlines realistic clinical paths starting with diseases like glaucoma/macular degeneration before elective ‘old-age’ rejuvenation.
- 2:12:50 – 2:19:26
Senolytics and “zombie cells”: clearing senescence vs resetting identity
They close on another major anti-aging avenue: senolytics, drugs designed to remove senescent cells that drive inflammation and tissue dysfunction. Sinclair ties senescence to epigenetic identity loss and describes the state of companies and trials, positioning senolytics as a potentially nearer-term intervention than full reprogramming.
